Inhaled RNA Might Help Heal Cystic Fibrosis

Scientists are working to correct a genetic defect in cystic fibrosis patients by having them inhale RNA. Christopher Intagliata reports.

Illustration of a Bohr atom model spinning around the words Science Quickly with various science and medicine related icons around the text

Join Our Community of Science Lovers!

Your genome is sort of like a library—with each gene an instruction manual for making proteins. Bad news is, you can’t return a book and take out a new edition. But the technique of gene therapy allows you to revise your copy of the book, so to speak…giving you the ability, potentially, to make new and different proteins.

Now scientists have experimented with a new way to make text revisions—by inhaling the changes. They tested the concept by having mice breathe in genetic material called messenger RNA, or mRNA. For the test, the mRNA included instructions to manufacture luciferase—the stuff that lights up in fireflies. 

The researchers packaged the mRNA with a degradable polymer, to trick the mice's lung cells into accepting the package. And once the cells gobbled it up, they began to glow—proving that inhaling mRNA is an effective way to kick-start the production of new and novel proteins, like the firefly enzyme. 


On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.


The scientists also repeated the experiment in mice whose cells had been genetically engineered to turn permanently red if they received a copy of mRNA—making it possible to count the proportion of cells affected by a dose. The proof of concept is in the journal Advanced Materials. [Asha Kumari Patel et al., Inhaled Nanoformulated mRNA Polyplexes for Protein Production in Lung Epithelium]

Of course, the point isn't to make mice glow. Instead, one idea is to use this technique to help cystic fibrosis patients. People with CF have a genetic mutation that causes a buildup of sticky mucus in their lungs. Several of the study authors work with a publicly traded biotech company called Translate Bio, which is conducting phase 1 and 2 trials to determine if inhaling messenger RNA could provide a genetic fix for cystic fibrosis. Regardless of the particular case of CF, the luciferase example shows that inhalation genetic therapy could be an inspiration. 

—Christopher Intagliata

[The above text is a transcript of this podcast.]

It’s Time to Stand Up for Science

If you enjoyed this article, I’d like to ask for your support. Scientific American has served as an advocate for science and industry for 180 years, and right now may be the most critical moment in that two-century history.

I’ve been a Scientific American subscriber since I was 12 years old, and it helped shape the way I look at the world. SciAm always educates and delights me, and inspires a sense of awe for our vast, beautiful universe. I hope it does that for you, too.

If you subscribe to Scientific American, you help ensure that our coverage is centered on meaningful research and discovery; that we have the resources to report on the decisions that threaten labs across the U.S.; and that we support both budding and working scientists at a time when the value of science itself too often goes unrecognized.

In return, you get essential news, captivating podcasts, brilliant infographics, can't-miss newsletters, must-watch videos, challenging games, and the science world's best writing and reporting. You can even gift someone a subscription.

There has never been a more important time for us to stand up and show why science matters. I hope you’ll support us in that mission.

Thank you,

David M. Ewalt, Editor in Chief, Scientific American

Subscribe